Effects of Xanthium stramarium and Psoralea corylifolia Extracts Combined with UVA1 Irradiation on the Cell Proliferation and TGF-beta1 Expression of Keloid Fibroblasts.
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Sun Yi PARK
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Ji Youn PARK
			        		
			        		;
		        		
		        		
		        		
			        		Chul Ho KIM
			        		
			        		;
		        		
		        		
		        		
			        		Sung Un KANG
			        		
			        		;
		        		
		        		
		        		
			        		Jong Hyun KIM
			        		
			        		;
		        		
		        		
		        		
			        		Ki Min BARK
			        		
			        		;
		        		
		        		
		        		
			        		Tae Heung KIM
			        		
			        		;
		        		
		        		
		        		
			        		Sung Chul SHIN
			        		
			        		;
		        		
		        		
		        		
			        		Hee Young KANG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Original Article
 - Keywords: Apoptosis; Keloid; Psoralea corylifolia; Transforming growth factor-beta 1; Xanthium stramarium
 - MeSH: Apoptosis; Asian Continental Ancestry Group; Cell Proliferation; Cell Survival; Collagen; Fibroblasts; Humans; Keloid; Plants, Medicinal; Psoralea; Therapeutic Uses; Transforming Growth Factor beta1; Xanthium
 - From:Annals of Dermatology 2013;25(3):304-309
 - CountryRepublic of Korea
 - Language:English
 - Abstract: BACKGROUND: Xanthium stramarium (XAS) and Psoralea corylifolia (PSC), phototoxic oriental medicinal plants, has been used in traditional medicines in Asian countries. OBJECTIVE: The effects of highly purified XAS or PSC extract combined with ultraviolet A1 (UVA1) irradiation on cell proliferation and transforming growth factor-beta1 (TGF-beta1) expression of the keloid fibroblast were being investigated to define potential therapeutic uses for keloid treatments. METHODS: The keloid fibroblasts were treated with XAS or PSC alone or in the combination with UVA1 irradiation. The cell viability, apoptosis, and expression of TGF-beta1 and collagen I were investigated. RESULTS: XAS and PSC in combination with UVA1 irradiation suppressed cell proliferation and induced apoptosis of keloid fibroblasts. Furthermore, the XAS and PSC in combination with UVA1 irradiation inhibited TGF-beta1 expression and collagen synthesis in keloid fibroblasts. CONCLUSION: These findings may open up the possibility of clinically used XAS or PSC in combination with UVA1 irradiation for keloid treatments.
 
            